The 26 S Proteasome: From Basic Mechanisms to Drug Targeting

The regulated degradation of proteins within eukaryotes and bacterial cells is catalyzed primarily by large multimeric proteases in ATP-dependent manner. In eukaryotes, the 26 S proteasome is essential for the rapid destruction of key regulatory proteins, such as cell cycle regulators and transcription factors, whose fast and tuned elimination is necessary for the proper control of the fundamental cell processes they regulate. In addition, the 26 S proteasome is responsible for cell quality control by eliminating defective proteins from the cytosol and endoplasmic reticulum. These defective proteins can be misfolded proteins, nascent prematurely terminated polypeptides, or proteins that fail to assemble into complexes. These diverse activities and its central role in apoptosis have made the proteasome an important target for drug development, in particular to combat malignancies. The regulated degradation of proteins within eukaryotes and bacterial cells is catalyzed primarily by large multimeric proteases in ATP-dependent manner. In eukaryotes, the 26 S proteasome is essential for the rapid destruction of key regulatory proteins, such as cell cycle regulators and transcription factors, whose fast and tuned elimination is necessary for the proper control of the fundamental cell processes they regulate. In addition, the 26 S proteasome is responsible for cell quality control by eliminating defective proteins from the cytosol and endoplasmic reticulum. These defective proteins can be misfolded proteins, nascent prematurely terminated polypeptides, or proteins that fail to assemble into complexes. These diverse activities and its central role in apoptosis have made the proteasome an important target for drug development, in particular to combat malignancies. Marking Proteins for DegradationTargeting of most substrates to the 26 S proteasome requires their prior marking by a covalently linked polyubiquitin chain(s). During association with the proteasome, the substrate is directed into the catalytic core, where it is digested, whereas most of the ubiquitin molecules are recycled.Protein ubiquitination is a multistep process orchestrated by the concerted action of three enzymes. The reaction begins with E1, 2The abbreviations used are: E1ubiquitin-activating enzymeE2ubiquitin-conjugating enzymeE3ubiquitin-protein ligaseUPSubiquitin-proteasome systemMMmultiple myelomaJNKc-Jun N-terminal kinaseERendoplasmic reticulumUPRunfolded protein response. which initially adenylates the C-terminal glycine of ubiquitin and then forms a thioester bond between the activated glycine residue and a cysteine residue on the E1 catalytic site. Next, E2 acquires the activated ubiquitin through a transthioesterification reaction to form a similar thioester bond between the E2 active-site cysteine and the activated ubiquitin. Finally, E3 recruits the target protein and guides the transfer of the activated ubiquitin from the E2 enzyme to the substrate. In most cases, an ϵ-NH2 group of a lysine residue on the substrate attacks the thioester bond between the ubiquitin and E2, and an isopeptide bond is formed, linking the activated C-terminal glycine of ubiquitin to the amino group in the attacking lysine of the target substrate (1.Pickart C.M. Eddins M.J. Biochim. Biophys. Acta. 2004; 1695: 55-72Crossref transfer from the E2 enzyme to the substrate is catalyzed by E3 and a to E3 is the The process is in a in a of ubiquitin is to an lysine residue of the polyubiquitin is as the for the 26 S in of have a in a that a polyubiquitin can be initially on the active-site cysteine of E2 by the action of an E2 in an E3 enzyme the transfer of the polyubiquitin to a lysine residue of the target substrate of a substrate of In a and that the polyubiquitin on the E2 of is by the proteasome and as a degradation in an forms of ubiquitination have or have where or ubiquitin are to lysine on the they These forms of ubiquitination in cell which and of proteins to cell in of such as the of the of the transcription is the most form of of proteins for degradation ubiquitin lysine and in polyubiquitin can be on of of can be or The that degradation is by on as the residue C.M. on have in proteins to the proteasome 26 S proteasome is a large of on and in the of can be into the S catalytic which is the and the S regulatory which to be responsible for and the substrates into the S proteasome, where they are is a protein made of and The are on the which are the of The catalytic activities of are with their N-terminal residue that as a in of the 26 S proteasome is to with of the an as a for of the from of the to the the S is formed, as the and N-terminal In addition, the in the is by a made of the N-terminal of the The are to of the S proteasome and degradation of the of that directed the process and the S proteasome with a S regulatory to form the 26 S proteasome a that association with the S the of the in the S which are on the of the S of the and into the S proteasome a in the proteasome to of the by the N-terminal that the to the of the into the of the the and substrate from the S into the S the S proteasome forms with such as and The of regulators in the cell are are by and are in of the have to in of the three catalytic and These the proteasome with and which the of the proteasome to degradation for can most amino substrates three The a the a and the a or The of the proteasome are the of the and are from the In addition, the in the through which substrates the S is can the S a substrate be by the of the S to be and within the S S regulatory is a large of and of of form a whereas the the the of the S Biophys. and Biophys. that the are with the of the S In to which are the and the between the of their amino are the N-terminal and the have as to a role in the to substrate whereas in the of the polyubiquitin C.M. is a ubiquitin 2004; to be in to with a of ubiquitin that proteins to the These proteins, and are of the proteasome with it a their that their by In addition, which is a S enzyme that is to have a central role in ubiquitin by polyubiquitin on the target substrate is by through a similar The of are The to ubiquitin such as and to the of the regulatory is by to cell the a protein that is made of and that is in the and the of E3 its to the from the of ubiquitin the enzyme in the S is essential for in is similar to the of the important to the proteasome is the of the that ubiquitin. the to be and to ubiquitin through of for that the S can polyubiquitin in a that requires C.M. which to the S through its N-terminal to polyubiquitin that are to the proteasome 2004; The of proteins ubiquitin whereas their with the proteasome through and through ubiquitin and are the of and in to be a These that an to be that the of the ubiquitin it is that proteins and in and that of their are it is the of is as a of the is The E1 the is for of and the E2 in to a role in the of the polyubiquitin The E3 the and the with its for its The proteasome the where the most substrates a the polyubiquitin with the association between an E3 and its to be the most for drug an of on the and the that large that of complexes. the and of proteases and to the of and which the of the proteasome to the drug are that the the is to the residue of the and the residue in the S of the are and 2004; the is The and are in the a of from in the The to the and the of the that proteasome can drug from the that they can apoptosis in and cells Biophys. and in by the and of the is as and as a drug for the of 2004; is a cell by cells in is by and that from of the and The can of the is of a that can be in the and that to the for of and of malignancies. The of the is to which that are in the The of the is with a of in the have that is in with and a in is in the of the enzyme in the of the where it as a for is that the with proteasome to in such as have to their on cells is of of the transcription The is activated in in of proteins and for drug and and and and and and and by for the are that such as the protein such as the of the protein to the and the degradation of the that is to the degradation a that of to the it that of the of proteasome as of the a on cell of the proteasome be that by proteasome cells to the of such as and that and by that their to the of proteasome to to is for of The that in the of the the from the and their it that proteasome can the of by of the proteasome can which to of proteins, of into the and of which the The can of by its which cells to that can apoptosis is the cells large of they are on degradation and the to the of misfolded proteins and to the that proteins of the proteasome the of the misfolded proteins in the and of the the is the of the which is responsible for of the that for a transcription of in the The of the of misfolded proteins in the and of the in of of proteasome to be as their of action are and to the proteasome In addition, they to have for the catalytic of the S the that is by to be by is that the of substrates by is from that by their on cells to be is on and for cell the on the These a of action in which the of the proteasome is to the of to of the the cells are to it is the of the cells to that the of action of the that of the have to is the of the enzyme of the of ubiquitin that processes such as the cell cycle and is essential for their that in Marking Proteins for DegradationTargeting of most substrates to the 26 S proteasome requires their prior marking by a covalently linked polyubiquitin chain(s). During association with the proteasome, the substrate is directed into the catalytic core, where it is digested, whereas most of the ubiquitin molecules are recycled.Protein ubiquitination is a multistep process orchestrated by the concerted action of three enzymes. The reaction begins with E1, 2The abbreviations used are: E1ubiquitin-activating enzymeE2ubiquitin-conjugating enzymeE3ubiquitin-protein ligaseUPSubiquitin-proteasome systemMMmultiple myelomaJNKc-Jun N-terminal kinaseERendoplasmic reticulumUPRunfolded protein response. which initially adenylates the C-terminal glycine of ubiquitin and then forms a thioester bond between the activated glycine residue and a cysteine residue on the E1 catalytic site. Next, E2 acquires the activated ubiquitin through a transthioesterification reaction to form a similar thioester bond between the E2 active-site cysteine and the activated ubiquitin. Finally, E3 recruits the target protein and guides the transfer of the activated ubiquitin from the E2 enzyme to the substrate. In most cases, an ϵ-NH2 group of a lysine residue on the substrate attacks the thioester bond between the ubiquitin and E2, and an isopeptide bond is formed, linking the activated C-terminal glycine of ubiquitin to the amino group in the attacking lysine of the target substrate (1.Pickart C.M. Eddins M.J. Biochim. Biophys. Acta. 2004; 1695: 55-72Crossref transfer from the E2 enzyme to the substrate is catalyzed by E3 and a to E3 is the The process is in a in a of ubiquitin is to an lysine residue of the polyubiquitin is as the for the 26 S in of have a in a that a polyubiquitin can be initially on the active-site cysteine of E2 by the action of an E2 in an E3 enzyme the transfer of the polyubiquitin to a lysine residue of the target substrate of a substrate of In a and that the polyubiquitin on the E2 of is by the proteasome and as a degradation in an forms of ubiquitination have or have where or ubiquitin are to lysine on the they These forms of ubiquitination in cell which and of proteins to cell in of such as the of the of the transcription is the most form of of proteins for degradation ubiquitin lysine and in polyubiquitin can be on of of can be or The that degradation is by on as the residue C.M. on have in proteins to the proteasome of most substrates to the 26 S proteasome requires their prior marking by a covalently linked polyubiquitin chain(s). During association with the proteasome, the substrate is directed into the catalytic core, where it is digested, whereas most of the ubiquitin molecules are ubiquitination is a multistep process orchestrated by the concerted action of three enzymes. The reaction begins with E1, 2The abbreviations used are: E1ubiquitin-activating enzymeE2ubiquitin-conjugating enzymeE3ubiquitin-protein ligaseUPSubiquitin-proteasome systemMMmultiple myelomaJNKc-Jun N-terminal kinaseERendoplasmic reticulumUPRunfolded protein response. which initially adenylates the C-terminal glycine of ubiquitin and then forms a thioester bond between the activated glycine residue and a cysteine residue on the E1 catalytic site. Next, E2 acquires the activated ubiquitin through a transthioesterification reaction to form a similar thioester bond between the E2 active-site cysteine and the activated ubiquitin. Finally, E3 recruits the target protein and guides the transfer of the activated ubiquitin from the E2 enzyme to the substrate. In most cases, an ϵ-NH2 group of a lysine residue on the substrate attacks the thioester bond between the ubiquitin and E2, and an isopeptide bond is formed, linking the activated C-terminal glycine of ubiquitin to the amino group in the attacking lysine of the target substrate (1.Pickart C.M. Eddins M.J. Biochim. Biophys. Acta. 2004; 1695: 55-72Crossref transfer from the E2 enzyme to the substrate is catalyzed by E3 and a to E3 is the The process is in a in a of ubiquitin is to an lysine residue of the polyubiquitin is as the for the 26 S in of have a in a that a polyubiquitin can be initially on the active-site cysteine of E2 by the action of an E2 in an E3 enzyme the transfer of the polyubiquitin to a lysine residue of the target substrate of a substrate of In a and that the polyubiquitin on the E2 of is by the proteasome and as a degradation in an enzyme enzyme N-terminal endoplasmic protein response. forms of ubiquitination have or have where or ubiquitin are to lysine on the they These forms of ubiquitination in cell which and of proteins to cell in of such as the of the of the transcription is the most form of of proteins for degradation ubiquitin lysine and in polyubiquitin can be on of of can be or The that degradation is by on as the residue C.M. on have in proteins to the proteasome The 26 S proteasome is a large of on and in the of can be into the S catalytic which is the and the S regulatory which to be responsible for and the substrates into the S proteasome, where they are is a protein made of and The are on the which are the of The catalytic activities of are with their N-terminal residue that as a in of the 26 S proteasome is to with of the an as a for of the from of the to the the S is formed, as the and N-terminal In addition, the in the is by a made of the N-terminal of the The are to of the S proteasome and degradation of the of that directed the process and the S proteasome with a S regulatory to form the 26 S proteasome a that association with the S the of the in the S which are on the of the S of the and into the S proteasome a in the proteasome to of the by the N-terminal that the to the of the into the of the the and substrate from the S into the S the S proteasome forms with such as and The of regulators in the cell are are by and are in of the have to in of the three catalytic and These the proteasome with and which the of the proteasome to degradation for can most amino substrates three The a the a and the a or The of the proteasome are the of the and are from the In addition, the in the through which substrates the S is can the S a substrate be by the of the S to be and within the S S regulatory is a large of and of of form a whereas the the the of the S Biophys. and Biophys. that the are with the of the S In to which are the and the between the of their amino are the N-terminal and the have as to a role in the to substrate whereas in the of the polyubiquitin C.M. is a ubiquitin 2004; to be in to with a of ubiquitin that proteins to the These proteins, and are of the proteasome with it a their that their by In addition, which is a S enzyme that is to have a central role in ubiquitin by polyubiquitin on the target substrate is by through a similar The of are The to ubiquitin such as and to the of the regulatory is by to cell the a protein that is made of and that is in the and the of E3 its to the from the of ubiquitin the enzyme in the S is essential for in is similar to the of the important to the proteasome is the of the that ubiquitin. the to be and to ubiquitin through of for that the S can polyubiquitin in a that requires C.M. which to the S through its N-terminal to polyubiquitin that are to the proteasome 2004; The of proteins ubiquitin whereas their with the proteasome through and through ubiquitin and are the of and in to be a These that an to be that the of the ubiquitin it is that proteins and in and that of their are it is the of is The 26 S proteasome is a large of on and in the of can be into the S catalytic which is the and the S regulatory which to be responsible for and the substrates into the S proteasome, where they are The is a protein made of and The are on the which are the of The catalytic activities of are with their N-terminal residue that as a in of the 26 S proteasome is to with of the an as a for of the from of the to the the S is formed, as the and N-terminal In addition, the in the is by a made of the N-terminal of the The are to of the S proteasome and degradation of the of that directed the process and the S proteasome with a S regulatory to form the 26 S proteasome a that association with the S the of the in the S which are on the of the S of the and into the S proteasome a in the proteasome to of the by the N-terminal that the to the of the into the of the the and substrate from the S into the S the S proteasome forms with such as and The of regulators in the cell are are by and are in of the have to in of the three catalytic and These the proteasome with and which the of the proteasome to degradation for can most amino substrates three The a the a and the a or The of the proteasome are the of the and are from the In addition, the in the through which substrates the S is can the S a substrate be by the of the S to be and within the S The S regulatory is a large of and of of form a whereas the the the of the S Biophys. and Biophys. that the are with the of the S In to which are the and the between the of their amino are the N-terminal and the have as to a role in the to substrate whereas in the of the polyubiquitin C.M. is a ubiquitin 2004; to be in to with a of ubiquitin that proteins to the These proteins, and are of the proteasome with it a their that their by In addition, which is a S enzyme that is to have a central role in ubiquitin by polyubiquitin on the target substrate is by through a similar The of are The to ubiquitin such as and to the of the regulatory is by to cell the a protein that is made of and that is in the and the of E3 its to the from the of ubiquitin the enzyme in the S is essential for in is similar to the of the important to the proteasome is the of the that ubiquitin. the to be and to ubiquitin through of for that the S can polyubiquitin in a that requires C.M. which to the S through its N-terminal to polyubiquitin that are to the proteasome 2004; The of proteins ubiquitin whereas their with the proteasome through and through ubiquitin and are the of and in to be a These that an to be that the of the ubiquitin it is that proteins and in and that of their are it is the of is The as a of the is The E1 the is for of and the E2 in to a role in the of the polyubiquitin The E3 the and the with its for its The proteasome the where the most substrates a the polyubiquitin with the association between an E3 and its to be the most for drug an of on the and the that large that of complexes. the and of proteases and to the of and which the of the proteasome to the drug are that the the is to the residue of the and the residue in the S of the are and 2004; the is The and are in the a of from in the The to the and the of the that proteasome can drug from the that they can apoptosis in and cells Biophys. and in by the and of the is as and as a drug for the of 2004; is a cell by cells in is by and that from of the and The can of the is of a that can be in the and that to the for of and of malignancies. The of the is to which that are in the The of the is with a of in the have that is in with and a in is in the of the enzyme in the of the where it as a for is that the with proteasome to in such as have to their on cells is of of the transcription The is activated in in of proteins and for drug and and and and and and and by for the are that such as the protein such as the of the protein to the and the degradation of the that is to the degradation a that of to the it that of the of proteasome as of the a on cell of the proteasome be that by proteasome cells to the of such as and that and by that their to the of proteasome to to is for of The that in the of the the from the and their it that proteasome can the of by of the proteasome can which to of proteins, of into the and of which the The can of by its which cells to that can apoptosis is the cells large of they are on degradation and the to the of misfolded proteins and to the that proteins of the proteasome the of the misfolded proteins in the and of the the is the of the which is responsible for of the that for a transcription of in the The of the of misfolded proteins in the and of the in of of proteasome to be as their of action are and to the proteasome In addition, they to have for the catalytic of the S the that is by to be by is that the of substrates by is from that by their on cells to be is on and for cell the on the These a of action in which the of the proteasome is to the of to of the the cells are to it is the of the cells to that the of action of the that of the have to is the of the enzyme of the of ubiquitin that processes such as the cell cycle and is essential for their that in The of the is The E1 the is for of and the E2 in to a role in the of the polyubiquitin The E3 the and the with its for its The proteasome the where the most substrates a the polyubiquitin with the association between an E3 and its to be the most for drug an of on the and the that large that of complexes. the and of proteases and to the of and which the of the proteasome to the drug are that the the is to the residue of the and the residue in the S of the are and 2004; the is The and are in the a of from in the The to the and the of the The that proteasome can drug from the that they can apoptosis in and cells Biophys. and in by the and of the is as and as a drug for the of 2004; is a cell by cells in is by and that from of the and The can of the is of a that can be in the and that to the for of and of malignancies. The of the is to which that are in the The of the is with a of in the have that is in with and a in is in the of the enzyme in the of the where it as a for is that the with proteasome to in such as have The to their on cells is of of the transcription The is activated in in of proteins and for drug and and and and and and and by for the are that such as the protein such as the of the protein to the and the degradation of the that is to the degradation a that of to the it that of the of proteasome as of the a on cell of the proteasome be that by proteasome cells to the of such as and that and by that their to the of proteasome to to is for of The that in the of the the from the and their it that proteasome can the of by of the proteasome can which to of proteins, of into the and of which the The can of by its which cells to that can apoptosis is the cells large of they are on degradation and the to the of misfolded proteins and to the that proteins of the proteasome the of the misfolded proteins in the and of the the is the of the which is responsible for of the that for a transcription of in the The of the of misfolded proteins in the and of the in of The of proteasome to be as their of action are and to the proteasome In addition, they to have for the catalytic of the S the that is by to be by is that the of substrates by is from that by their on cells to be is on and for cell the on the These a of action in which the The of the proteasome is to the of to of the the cells are to it is the of the cells to that the of action of the that of the have to is the of the enzyme of the of ubiquitin that processes such as the cell cycle and is essential for their that in with with